NERV
Minerva Neurosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.43
−5.54%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
195.6%
Return on equity
-414.7%
Return on assets
17.4%
Return on invested capital
0.00x
Asset turnover
-$18.8B
Cash from operations
$1.58
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026